Suppr超能文献

低密度脂蛋白受体相关蛋白(LRP)的C末端37个残基可促进淀粉样前体蛋白(APP)的淀粉样生成过程,且不依赖于FE65。

C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65.

作者信息

Lakshmana Madepalli K, Chen Eunice, Yoon Il-Sang, Kang David E

机构信息

Department of Neurosciences, University of California, San Diego, Gilman Drive, La Jolla, CA 92093, USA.

出版信息

J Cell Mol Med. 2008 Dec;12(6B):2665-74. doi: 10.1111/j.1582-4934.2008.00320.x. Epub 2008 Mar 28.

Abstract

The major defining pathological hallmark of Alzheimer's disease (AD) is the accumulation of amyloid beta protein (Abeta), a small peptide derived from beta- and gamma-secretase cleavages of the amyloid precursor protein (APP). Recent studies have shown that the Low-density lipoprotein receptor-related protein (LRP) plays a pivotal role in the trafficking of APP and generation of Abeta. In particular, we recently showed that the soluble cytoplasmic tail of LRP (LRP-ST) without a membrane tether was sufficient to promote Abeta generation. In this study, we demonstrate that the last 37 residues of LRP cytoplasmic tail (LRP-C37) lacking the NPxY motifs and FE65 binding mediate the core pro-amyloidogenic activity of LRP-ST. Moreover, we show that the conserved dileucine motif within the LRP-C37 region is a key determinant of its Abeta promoting activity. Finally, results from a yeast two-hybrid screen using LRP-C37 region as bait reveal four new LRP-binding proteins implicated in intracellular signalling and membrane protein trafficking. Our findings indicate that the LRP-C37 sequence represents a new protein-binding domain that may be useful as a therapeutic target and tool to lower Abeta generation in AD.

摘要

阿尔茨海默病(AD)的主要病理学标志性特征是β淀粉样蛋白(Aβ)的积累,Aβ是一种由淀粉样前体蛋白(APP)经β-和γ-分泌酶切割产生的小肽。最近的研究表明,低密度脂蛋白受体相关蛋白(LRP)在APP的转运和Aβ的产生中起关键作用。特别是,我们最近发现,没有膜连接的LRP可溶性细胞质尾巴(LRP-ST)足以促进Aβ的产生。在本研究中,我们证明,缺乏NPxY基序和FE65结合的LRP细胞质尾巴的最后37个残基(LRP-C37)介导了LRP-ST的核心促淀粉样蛋白生成活性。此外,我们表明,LRP-C37区域内保守的双亮氨酸基序是其促进Aβ活性的关键决定因素。最后,以LRP-C37区域为诱饵进行的酵母双杂交筛选结果揭示了四种新的与细胞内信号传导和膜蛋白转运有关的LRP结合蛋白。我们的研究结果表明,LRP-C37序列代表了一个新的蛋白结合结构域,可能作为治疗靶点和降低AD中Aβ产生的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a7f/3828882/d19fa7a3fa8a/jcmm0012-2665-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验